(Q38459411)

English

Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease. Eptastigmine Study Group.

scientific article published on August 1996

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823240%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease. Eptastigmine Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823240%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Alzheimer's disease

0 references

pharmacodynamics

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823240%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

author name string

Canal N

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823240%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

language of work or name

0 references

publication date

1 August 1996

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823240%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823240%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

60

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823240%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823240%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

218-228

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823240%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

21 January 2018

STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

21 January 2018

Memory Enhancement After Physostigmine Treatment in the Amnesic Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

21 January 2018

Long-term administration of oral physostigmine in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

21 January 2018

Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

21 January 2018

Oral physostigmine treatment of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

21 January 2018

Anticholinesterase activity of a new carbamate, heptylphysostigmine, in view of its use in patients with Alzheimer-type dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

A long-lasting cholinesterase inhibitor affecting neural and behavioral processes

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

The behavioral effects of heptyl physostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Reversal of cognitive impairment by heptyl physostigmine, a long-lasting cholinesterase inhibitor, in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Kinetics of cholinesterase inhibition by eptastigmine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Relationship between pharmacokinetics and pharmacodynamics of eptastigmine in young healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

A multiple-dose safety trial of eptastigmine in Alzheimer's disease, with pharmacodynamic observations of red blood cell cholinesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Acetylcholinesterase in the human erythron. II. Biochemical assay

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Diagnostic evaluation of degenerative and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

A patient-side technique for real-time measurement of acetylcholinesterase activity during monitoring of eptastigmine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Determination of heptylphysostigmine in plasma by high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Memory deficits in aged cebus monkeys and facilitation with central cholinomimetics

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Learning impairment following lesion of the basal nucleus of Meynert in the marmoset: modification by cholinergic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Effect of a novel CNS-selective cholinesterase inhibitor, SM-10888, on habituation and passive avoidance responses in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Measurement of erythrocyte acetylcholinesterase and plasma cholinesterase activity by a differential pH technique

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Rapid potentiometric determination of cholinesterases in plasma and red cells: application to eptastigmine monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Cholinergic receptor interactions and their effects on long-term memory processing.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Cholinergic modulation of memory in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Effects of the novel compound NIK-247 on impairment of passive avoidance response in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in vivo pharmacological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Autoregulation of acetylcholine release in isolated hippocampal nerve endings

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

An in vivo pharmacological study on muscarinic receptor subtypes regulating cholinergic neurotransmission in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Muscarinic receptors mediate attenuation of extracellular acetylcholine levels in rat cerebral cortex after cholinesterase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990138-1

7 January 2021

Identifiers

10.1016/S0009-9236(96)90138-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823240%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823240%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38459411&oldid=2143845547"